• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

2 Minute Medicine Rewind: May 13 – May 19

bys25qthea
June 22, 2013
in Cardiology, Infectious Disease, Weekly Rewinds
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

May 13 – 19, 2013

In this section, we will highlight the some of the recent high-impact studies, updates, and analyses published in the past week.

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

Reminiscent of past SARS or H1N1 epidemics, a new rapidly progressing lower respiratory tract infection leading to ARDS and with high mortality was identified in eastern China near Shanghai in March 2013. Using samples obtained from three patients, a novel influenza (N7N9) virus was identified and sequenced to show reassortment of genes from multiple avian-origin viral strains, suggesting direct avian transmission.

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection 

In two similar studies, sofosuvir (a new nucleotide polymerase inhibitor) and ribavarin was studied for the treatment of chronic Hepatitis C infection. In the first study of patients with chronic HCV (genotype 2 or 3) infection not eligible for peginterferon, a twelve week course of sofosbuvir -ribavarin had a greater sustained virologic response compared to placebo (78% vs. 0%). In the second study, a head to head comparison of sofosuvir-ribavarin with peginterferon-ribavarin had similar rates of response (67%) however with fewer side effects in the sofosuvir-ribavarin arm. In both trials, there was a better response in patients with genotype 2 than genotype 3 HCVs.

RELATED REPORTS

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

The Moderna mRNA vaccine prevents COVID-19 infection in adolescents

AREDS2 Trial: Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration 

Although previous studies have shown supplementation with vitamin C and E, beta carotene, and zinc decreases the progression of age related macular degeneration, this mlticenter RCT showed there was no benefit to adding either lutein, zeaxanthin, or omega-3 fatty acids to the regimen. 

Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention

A retrospective analysis of Medicare claims data failed to show a difference in 1-year hospitalization rate (43.9% vs. 44.8%) and mortality (9.9% vs. 9.8%) between patients with single chamber vs. dual chamber ICDs placed for primary prevention. There was a statistically significant lower rate of complication with single chamber ICDs compared to dual chamber ICDs (3.5% vs. 4.7%). 

By David Ouyang

Tags: dual chamber ICDH7N9hepatitis Cinfluenzamacular degenerationnucleotide polymerase inhibitorrewindribavarinsofosuvirvaccine
Previous Post

Music therapy reduces anxiety and sedative requirements in the ICU

Next Post

Delayed tracheostomy in critically ill does not increase mortality

RelatedReports

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Infectious Disease

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

June 24, 2022
Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

June 22, 2022
Waning Tdap vaccine effectiveness among adolescents
Infectious Disease

The Moderna mRNA vaccine prevents COVID-19 infection in adolescents

June 20, 2022
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Plant-based CoVLP+AS03 vaccine protects against COVID-19 infection

June 18, 2022
Next Post
Delayed tracheostomy in critically ill does not increase mortality

Delayed tracheostomy in critically ill does not increase mortality

Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

Prone positioning decreases mortality in severe ARDS (PROSEVA Trial)

Prone positioning decreases mortality in severe ARDS (PROSEVA Trial)

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.